Patents by Inventor Kimmo Porkka

Kimmo Porkka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Patent number: 9320810
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: April 26, 2016
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Patent number: 8598112
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: December 3, 2013
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Patent number: 8329859
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: December 11, 2012
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Erkki I. Ruoslahti
  • HMGN2 PEPTIDES AND RELATED MOLECULES THAT SELECTIVELY HOME TO TUMOR BLOOD VESSELS AND TUMOR CELLS
    Publication number: 20120121501
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Application
    Filed: October 18, 2011
    Publication date: May 17, 2012
    Applicant: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Patent number: 8048983
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: November 1, 2011
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Publication number: 20110165083
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Application
    Filed: January 22, 2010
    Publication date: July 7, 2011
    Applicant: Burnham Institute for Medical Research
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Erkkil Ruoslahti
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Patent number: 7671021
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: March 2, 2010
    Assignee: Burnham Institute for Medical Research
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Erkki Ruoslahti
  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Patent number: 7544767
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: June 9, 2009
    Assignee: Burnham Institute for Medical Research
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Publication number: 20090098633
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 16, 2009
    Applicant: Burnham Institute for Medical Research
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Publication number: 20070149444
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Application
    Filed: February 27, 2007
    Publication date: June 28, 2007
    Applicant: THE BURNHAM INSTITUTE
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason Hoffman, Erkki Ruoslahti
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Patent number: 7192921
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: March 20, 2007
    Assignee: The Burnham Institute
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Erkki Ruoslahti
  • HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
    Publication number: 20040186056
    Abstract: The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.
    Type: Application
    Filed: March 20, 2003
    Publication date: September 23, 2004
    Inventors: Erkki Ruoslahti, Kimmo Porkka, Sven Christian
  • Peptides that home to tumor lymphatic vasculature and methods of using same
    Publication number: 20040087499
    Abstract: The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature.
    Type: Application
    Filed: November 5, 2002
    Publication date: May 6, 2004
    Inventors: Pirjo Laakkonen, Kimmo Porkka, Jason A. Hoffman, Erkki Ruoslahti